Hwanhee Kim

Xu Wenxin, Chen Jason Zhang, Xiaoyong Wei et al.

Text-to-Visualization (Text-to-Vis) translates natural language queries into visualization query languages, enabling non-expert users to perform data analysis. However, most existing methods follow a one-shot paradigm that requires users to specify all visualization details in a single round, often leading to cognitive overload and incorrect visualizations. In this paper, we propose PMVis, a progressive multi-turn paradigm for text-to-vis, where users' intents are refined through multi-turn interactions. To support research in this paradigm, we construct PMVisBench, the first dataset designed to capture the progressive and iterative nature of real-world user queries. It is built through VQL simplification and NLQ reconstruction, with explicit rule constraints to ensure each intermediate VQL remains valid and meaningful. Building upon PMVis, we further introduce PMVisAgent, an agent-based framework that simulates realistic user-system dialogues. PMVisAgent consists of a User, a System, and a Validation Agent that performs verification and repair via a ReAct-style tool-use loop to mitigate error accumulation across rounds, with explicit interaction and verification rules to ensure reliability of the multi-agent system. Extensive experiments on PMVisBench demonstrate that PMVisAgent significantly outperforms state-of-the-art text-to-vis baselines. It achieves up to 17.57\% and 23.21\% improvements in execution accuracy in single-table and multi-table settings, respectively, while ablation studies confirm the importance of combining progressive interaction with clarification. The code is available at https://github.com/wxxv/PMVis.

Seungyeon Choi, Hwanhee Kim, Chihyun Park et al.

Recent advances in Structure-based Drug Design (SBDD) have leveraged generative models for 3D molecular generation, predominantly evaluating model performance by binding affinity to target proteins. However, practical drug discovery necessitates high binding affinity along with synthetic feasibility and selectivity, critical properties that were largely neglected in previous evaluations. To address this gap, we identify fundamental limitations of conventional diffusion-based generative models in effectively guiding molecule generation toward these diverse pharmacological properties. We propose CByG, a novel framework extending Bayesian Flow Network into a gradient-based conditional generative model that robustly integrates property-specific guidance. Additionally, we introduce a comprehensive evaluation scheme incorporating practical benchmarks for binding affinity, synthetic feasibility, and selectivity, overcoming the limitations of conventional evaluation methods. Extensive experiments demonstrate that our proposed CByG framework significantly outperforms baseline models across multiple essential evaluation criteria, highlighting its effectiveness and practicality for real-world drug discovery applications.